Orchid Pharma (NSE:ORCHPHARMA, BOM:524372) has signed an agreement with the insolvency administrator of Allecra Therapeutics (Germany) to acquire all assets of Allecra, according to an Indian bourse filing Wednesday.
Shares of the company jumped 5% in Thursday's trade.
The assets include intellectual property, trademarks, customer contracts, regulatory filings, and tangible and intangible assets, the filing said.
Meanwhile, a French court on July 30 accepted Orchid's binding bid-submitted with the concurrence of the insolvency administrator of Allecra Therapeutics SAS-for acquisition of similar assets, the filing said.
A formal order is expected shortly, it added.
Upon completion, Orchid Pharma will reclaim 100% global ownership of enmetazobactam, the first novel antibiotic molecule discovered in India.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。